Article

Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal…

Journal of Immunology Research · 2018 · Qing Zhang, author Haixu Zhang, author Jiage Ding, author Hongyan Liu, author Huizhong Li, author Hailong Li, author Mengmeng Lu, author Yangna Miao, author Liantao Li, author Junnian Zheng, author Lei Zhao, Academic Editor

Key facts

Title Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
First author Qing Zhang, author Haixu Zhang, author Jiage Ding, author Hongyan Liu, author Huizhong Li, author Hailong Li, author Mengmeng Lu, author Yangna Miao, author Liantao Li, author Junnian Zheng, author Lei Zhao, Academic Editor
Journal Journal of Immunology Research
Published Apr 19, 2018
DOI 10.1155/2018/4263520
Devices mentioned BK110039, DEN000008, K022086, K781043
Product codes mentioned JCI, KIP, KIT, MVU, NDS, JRL, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature